Barinthus Biotherapeutics
Manufacturing · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Zeus Building unit 6-10 Rutherford Harwe...Phone Number
+44 1865818808Website
www.barinthusbio.comRevenue
-Stock Symbol
BRNSIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Barinthus Biotherapeutics
Barinthus Biotherapeutics is a clinicalstage biopharmaceutical company focused on developing novel immunotherapies that guide the bodys T cells to treat chronic infectious diseases, autoimmune diseases, and inflammatory conditions. The firm leverages its proprietary platforms to create antigenspecific immunotherapeutic candidates designed to restore immune balance, suppress inappropriate immune responses, or stimulate targeted immunity against disease. Originally spun out of university and researchinstitution work, Barinthus has evolved beyond traditional vaccines and now emphasizes Tcell immunotherapy for conditions such as chronic viral infections, autoimmune disorders, and cancer. The companys mission centers on improving patient outcomes by using advanced immunology research to offer potentially transformative therapiesExplore more
Barinthus Biotherapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Barinthus Biotherapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Barinthus Biotherapeutics has recently received funding, and reach out quickly before it becomes old news!
Barinthus Biotherapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Barinthus Biotherapeutics
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Barinthus Biotherapeutics recently announced quarterly report
Check out if Barinthus Biotherapeutics is spiking on competitors!
Product Launch: Get notified when Barinthus Biotherapeutics launches new products
Funding: Get notified immidiatlly once Barinthus Biotherapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Barinthus Biotherapeutics had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Barinthus Biotherapeutics
Find 3 more new buyers
Compare Similar Companies to Barinthus Biotherapeutics
Compare insights from companies similar to Barinthus Biotherapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Barinthus Biotherapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Barinthus Biotherapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Barinthus Biotherapeutics.
Barinthus Biotherapeutics Tech Stack
A closer look at the technologies used by Barinthus Biotherapeutics
See more technologies
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
New Hire
Executive Move
Executive Moves, New Hire
Earnings
Earnings, Finance
Project
Laboratory Operations, Medical Research, Clinical Operations
New Hire
Executive Move
Executive Moves, New Hire
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Barinthus Biotherapeutics
Sign Up For FreeTo access detailed company insights
Barinthus Biotherapeutics is a clinicalstage biopharmaceutical company focused on developing novel immunotherapies that guide the bodys T cells to treat chronic infectious diseases, autoimmune diseases, and inflammatory conditions. The firm leverages its proprietary platforms to create antigenspecific immunotherapeutic candidates designed to restor... Read More
